Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

ACRS Aclaris Therapeutics Inc

3,63

0,00 (0,00%)

Avant marché

Dernière mise à jour : 12:10:35

Retardé de 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Aclaris Therapeutics (NASDAQ:ACRS)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024

Plus de graphiques de la Bourse Aclaris Therapeutics

Aclaris Therapeutics (NASDAQ:ACRS)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024

Plus de graphiques de la Bourse Aclaris Therapeutics

Actualités Aclaris Therapeutics Inc

Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
Mardi 26 Novembre 2024 ( il y a 14 heures) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Lundi 25 Novembre 2024 ( il y a 2 jours) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Lundi 25 Novembre 2024 ( il y a 2 jours) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Vendredi 22 Novembre 2024 ( il y a 5 jours) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jeudi 21 Novembre 2024 ( il y a 6 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 20 Novembre 2024 ( il y a 7 jours) • Edgar (US Regulatory)

This Healthcare Stock Soared Following Exclusive License Agreement Announcement
Mardi 19 Novembre 2024 ( il y a 1 semaine) • AllPennyStocks.com

Form 3 - Initial statement of beneficial ownership of securities
Lundi 18 Novembre 2024 ( il y a 1 semaine) • Edgar (US Regulatory)

Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets
Lundi 18 Novembre 2024 ( il y a 1 semaine) • PR Newswire (US)

Form 8-K - Current report
Lundi 18 Novembre 2024 ( il y a 1 semaine) • Edgar (US Regulatory)

Aclaris Therapeutics Announces $80 Million Private Placement
Lundi 18 Novembre 2024 ( il y a 1 semaine) • GlobeNewswire Inc.

Aclaris Therapeutics Announces Exclusive, Global License Agreement with Biosion, Inc., adding Potential Best-in-Class Biologics Assets to Pipeline
Lundi 18 Novembre 2024 ( il y a 1 semaine) • GlobeNewswire Inc.

Plus d'articles sur Aclaris Therapeutics Inc

Poligrafici Printing

Vontobel Financial Produ...

Champion Industries (CE)

BNP Paribas Issuance

BNP Paribas Issuance

Hsi Malls Fundo DE Inves...

BNP Paribas Issuance

BNP Paribas Issuance

BNP Paribas Issuance

Finnovate Acquisition

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales